Verdiva Bio

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$411M

Verdiva Bio is a clinical-stage biopharmaceutical company developing next-generation oral and injectable treatments for obesity and cardiometabolic disorders.